InvestorsHub Logo
Followers 43
Posts 9124
Boards Moderated 0
Alias Born 01/06/2011

Re: None

Wednesday, 03/07/2012 9:32:05 AM

Wednesday, March 07, 2012 9:32:05 AM

Post# of 3332
DSCO could be acquired, says Roth Capital

After Discovery Labs' synthetic surfactant, Surfaxin, was approved by the FDA, Roth Capital thinks the company could sell itself, or obtain a partner. The firm believes that the FDA's approval significantly increases the value of the company's stock, and it raised its target on the shares to $10 from $6 while maintaining a Buy rating
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent WINT News